Aims and challenges of building national trainee networks in clinical microbiology and infectious disease disciplines.


Journal

Future microbiology
ISSN: 1746-0921
Titre abrégé: Future Microbiol
Pays: England
ID NLM: 101278120

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 7 7 2021
medline: 5 1 2022
entrez: 6 7 2021
Statut: ppublish

Résumé

Trainees represent the medical practice of tomorrow. Interactions and collaborations at the early stage in career will strengthen the future of our specialties, clinical microbiology and infectious diseases. Trainee networks at the national level help access the best education and career opportunities. The aim of this collaborative white paper between the Trainee Association of European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and four national trainee networks is to discuss the motivation for building such networks and offer guidance for their creation and sustainability even during a health crisis.

Identifiants

pubmed: 34227395
doi: 10.2217/fmb-2021-0045
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

687-695

Auteurs

Sarah Dellière (S)

Université de Paris, Service de Parasitologie-Mycologie, Hôpital Saint-Louis, AP-HP, Paris, France.

Nathan Peiffer-Smadja (N)

Université de Paris, Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, AP-HP, Paris, France.

Maria João-Lopes (M)

Infectious & Tropical Diseases Department, Hospital Prof Doutor Fernando Fonseca, Amadora, Portugal.

Muge Cevik (M)

Division of Infection & Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK.

Maxime Pichon (M)

Infectious Agents Department, CHU de Poitiers, Bacteriology & Infection Control Laboratory, Poitiers, France; Université de Poitiers, U1070 INSERM, Pharmacologie des Agents Anti-Infectieux, Poitiers, France.

Alexandre Bleibtreu (A)

Infectious & Tropical Diseases Departement, Pitié Salpêtrière hospital, APHP-SU, Paris, France.

Valentijn Schweitzer (V)

Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Katharina Last (K)

Institute of Medical Microbiology & Hygiene, Saarland University, Homburg/Saar, Germany.

Théo G Ferreira (TG)

Université de Paris, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.

Adrien Lemaignen (A)

Service de Médecine Interne et Maladies Infectieuses, CHRU de Tours, Université de Tours, Tours, France.

Aleksandra Barac (A)

Clinic for Infectious & Tropical Diseases, Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH